Confidence: 85%
B091MJVVZ7
View on Amazon →Decision summary
Not a strong option overall. The product is materially held back by weaker formulation coherence.
Best for
Only budget-focused buyers with flexible standards.
Consider another option if
You care a lot about label clarity and want fewer unknowns.
Score breakdown
Tap a module to see what it measures. A 0 can reflect missing disclosure, not just a negative result.
Dosage quality
1.4/10Dosing looks weaker than ideal
Checks whether labeled ingredient amounts fall within clinically studied ranges (not just regulatory minimums). Low/0 can reflect under-dosing or missing amounts (e.g., proprietary blends).
Explore next
Dose 1.4/10 · Bioavailability 2.9/10 · Coherence 0/10
Dose quality suggests a diluted formulation.
Ingredient form quality suggests suboptimal ingredient forms.
This is a multi-ingredient product. The score reflects formulation quality, not efficacy for a specific health goal.
The formula stays relatively clean on excipients. The main limitation is that berberine: below clinically studied range.
Strengths
Weaknesses
Final verdict
Not a strong option overall. The product is materially held back by weaker formulation coherence.
A closer look at the main ingredients, how they influence the score, and the supporting evidence when available. Tap any ingredient to expand.
⚠ Strong evidence exists, but dose is below effective threshold
One of the weaker points: Dose is likely below clinically useful levels. The declared form is acceptable, but not among the best-absorbed options.
Scientific evidence
Lan et al. meta-analysis berberine and lipid profile
Journal of Ethnopharmacology • 2015
PMID: 26448206.0
Dong et al. meta-analysis berberine and glycemic control in type 2 diabetes
Metabolism • 2012
PMID: 22162995.0
⚠ Dose is below commonly used clinical ranges
This is a limiting factor: Dose is likely below clinically useful levels.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
ℹ Dose is within established clinical ranges, but lacks direct studies
One of the weaker points: Dose is below the ranges usually used for stronger effects.
Clinical dosing guidance
Based on established dosing ranges used in clinical practice.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Evidence inferred from established knowledge, not directly linked studies
Solid but not a standout: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Evidence inferred from established knowledge, not directly linked studies
Adequate, but not a key strength: Clinical dosing guidance is limited for this ingredient.
No supporting studies or dosing references are currently available for this ingredient.
Important label or formulation details that may affect how this product should be interpreted.
Berberine dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Ceylon Cinnamon dose looks below clinically effective levels
Declared amount falls below ranges used in human trials.
Formula design looks less coherent than stronger alternatives
The formulation appears less focused than better-built options.
Read our methodology overview to understand how SuppScoreLab combines multiple scientific dimensions into one practical score.
View methodology →This evaluation is based on the product label and declared Supplement Facts available at review time. It does not verify laboratory-tested composition, purity, or batch-level quality. This content is educational and not medical advice. Consult a qualified healthcare professional for personal health decisions. Affiliate disclosure: SuppScoreLab may earn a commission from qualifying Amazon links.
See the best Berberine supplements ranked with the same methodology, or keep exploring the database.
